BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 9351717)

  • 1. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas.
    Z'graggen K; Rivera JA; Compton CC; Pins M; Werner J; Fernández-del Castillo C; Rattner DW; Lewandrowski KB; Rustgi AK; Warshaw AL
    Ann Surg; 1997 Oct; 226(4):491-8; discussion 498-500. PubMed ID: 9351717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters.
    Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM
    Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas.
    Izawa T; Obara T; Tanno S; Mizukami Y; Yanagawa N; Kohgo Y
    Cancer; 2001 Oct; 92(7):1807-17. PubMed ID: 11745253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.
    Sessa F; Solcia E; Capella C; Bonato M; Scarpa A; Zamboni G; Pellegata NS; Ranzani GN; Rickaert F; Klöppel G
    Virchows Arch; 1994; 425(4):357-67. PubMed ID: 7820300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of p21ras in pancreatic neoplasia and chronic pancreatitis.
    Mulligan NJ; Yang S; Andry C; Klein M; O'Brien MJ
    Hum Pathol; 1999 Jun; 30(6):602-10. PubMed ID: 10374765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of K-ras point mutation distributions in intraductal papillary-mucinous tumors and ductal adenocarcinoma of the pancreas.
    Kitago M; Ueda M; Aiura K; Suzuki K; Hoshimoto S; Takahashi S; Mukai M; Kitajima M
    Int J Cancer; 2004 Jun; 110(2):177-82. PubMed ID: 15069678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
    Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
    Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas.
    Mueller J; Gansauge S; Mattfeldt T
    Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas.
    Kondo H; Sugano K; Fukayama N; Hosokawa K; Ohkura H; Ohtsu A; Mukai K; Yoshida S
    Cancer; 1997 Mar; 79(5):900-5. PubMed ID: 9041151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive cancer and survival of intraductal papillary mucinous tumors of the pancreas.
    Raimondo M; Tachibana I; Urrutia R; Burgart LJ; DiMagno EP
    Am J Gastroenterol; 2002 Oct; 97(10):2553-8. PubMed ID: 12385438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive ductal adenocarcinoma of the remnant pancreatic body 9 years after resection of an intraductal papillary-mucinous carcinoma of the pancreatic head: a case report and comparison of DNA sequence in K-ras gene mutation.
    Komori T; Ishikawa O; Ohigashi H; Yamada T; Sasaki Y; Imaoka S; Nakaizumi A; Uehara H; Tanaka S; Mano Y; Kasugai T
    Jpn J Clin Oncol; 2002 Apr; 32(4):146-51. PubMed ID: 12072425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A two-step enriched-nested PCR technique enhances sensitivity for detection of codon 12 K-ras mutations in pancreatic adenocarcinoma.
    Banerjee SK; Makdisi WF; Weston AP; Campbell DR
    Pancreas; 1997 Jul; 15(1):16-24. PubMed ID: 9211488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors.
    Kaino M; Kondoh S; Okita S; Hatano S; Shiraishi K; Kaino S; Okita K
    Pancreas; 1999 Apr; 18(3):294-9. PubMed ID: 10206488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
    Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
    Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
    Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
    Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential accumulation of K-ras mutations and p53 overexpression in the progression of pancreatic mucinous cystic neoplasms to malignancy.
    Jimenez RE; Warshaw AL; Z'graggen K; Hartwig W; Taylor DZ; Compton CC; Fernández-del Castillo C
    Ann Surg; 1999 Oct; 230(4):501-9; discussion 509-11. PubMed ID: 10522720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does "clonal progression" relate to the development of intraductal papillary mucinous tumors of the pancreas?
    Wada K; Takada T; Yasuda H; Amano H; Yoshida M; Sugimoto M; Irie H
    J Gastrointest Surg; 2004; 8(3):289-96. PubMed ID: 15019925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoting effect of a high-fat/high-protein diet in DMBA-induced ductal pancreatic cancer in rats.
    Z'graggen K; Warshaw AL; Werner J; Graeme-Cook F; Jimenez RE; Fernández-Del Castillo C
    Ann Surg; 2001 May; 233(5):688-95. PubMed ID: 11323507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive genomic alterations in intraductal papillary mucinous tumours of the pancreas and morphologically similar lesions of the pancreatic ducts.
    Soldini D; Gugger M; Burckhardt E; Kappeler A; Laissue JA; Mazzucchelli L
    J Pathol; 2003 Apr; 199(4):453-61. PubMed ID: 12635136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.